Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

India Coronavirus Vaccine Market By Infection Type (SARS-CoV, MERS-CoV, SARS-CoV-2) By Vaccine Type (Virus vaccine, Viral vector vaccine, Nucleic acid vaccines, Protein based vaccine, Others) By Product Type (Monovalent Vaccine v/s Multivariant Vaccine) By Route of Administration (Oral, Intramuscular, Intranasal) By Patient Type (Pediatric v/s Adult) By End User (Hospitals, Clinics, Research Institutes, Others) By Region, Competition Forecast & Opportunities, FY2027

Need for protection against the Coronaviridae and its strains is driving the growth of India Coronavirus Vaccine Market, in the forecast period, FY2017-FY2027Read More

Global Acne Treatment Market By Therapeutic Class (Retinoids, Antibiotics, Hormonal Drugs, Anti-Inflammatory Drugs, Chemical Peels and Others) By Formulation (Topical Medications, Oral Medications and Injectables) By Type (Prescription Medicines and Over-The-Counter Medicines) By Acne Type (Cystic Acne, Postsurgical/Wound Acne, Comedonal Acne, Inflammatory Acne) By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores, and E-Commerce) By Company, By Region, Competition Forecast & Opportunities, 2026

Rising disposable income drives the growth of Global Acne Treatment Market, in the forecast period, 2022-2026.Read More

Global Bleeding Disorders Drugs Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026

Increasing number of patients with bleeding disorder is driving the Global Bleeding Disorders Drugs Market growth in the forecast period, 2022-2026. Read More

Global Generic Drugs Market By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Company, By Region, Forecast & Opportunities, 2026

Increasing demand for generic medicines is expected to drive the growth of global generic drugs market during the forecast period.Read More

Global Leukemia Therapeutics Market By Type (Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia, Others), By Gender (Male, Female), By Age Groups (0-15, 15-30, 30-50, 50+), By Diagnosis (Blood Test, Biopsy, Physical Exam, Imaging), By Treatment (Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, Others), By Drugs (Tyrosine Kinase Inhibitors, Antimetabolites, Hormones (Corticosteroids), Monoclonal Antibodies, Others), By Route of Administration (Oral, Parenteral), By Region, Competition Forecast & Opportunities, 2026

Increasing incidences of leukemia cases around the globe to drive the growth of global leukemia therapeutics marketRead More

India Haematology Analyzer Market By Product Type (Instruments, Reagents & Consumables and Services), By Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers), By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes), By Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune system related conditions and Others), By Automation (Automatic Hematology Analyzers v/s Semiautomatic Hematology Analyzers), By Company, By Region, Forecast & Opportunities, FY2027

Rising prevalence of blood disorder is expected to drive the growth of India haematology analyzer market during the forecast period.Read More

India Norfloxacin Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Eye drops, Syrup, Ointment and Injection), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Urinary tract Infections, Gynaecological Infections, Bladder Infections, Inflammation Of The Prostate Gland, Gonorrhoea And Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027

Growing urinary tract infections amongst population is expected to drive the growth of India norfloxacin market during the forecast period.Read More

Global Bleeding Disorders Treatment Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) By End User (Clinics, Hospitals, Research Institutes, Others) By Region, Competition Forecast & Opportunities, 2026

Increasing number of bleeding disorder patients is driving the Global Bleeding Disorders Treatment Market growth in the forecast period, 2022-2026.Read More

Global Central Nervous System Therapeutics Market By Drug Class (Analgesics, Anesthetics, Anticonvulsants, Antiepileptics, Anti-Parkinson Agents, Others) By Application (Neurovascular Diseases, Mental Health and Trauma, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer, Others) By Route of Administration (Oral, Parenteral, Others) By End Users (Hospitals, Clinics, Diagnostic Laboratories, Others) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) By Region, Competition Forecast & Opportunities, 2026

Demand for effective therapeutics for treatment of CNS is a driving factor for the growth of Global Central Nervous System Therapeutics Market in forecast period.Read More

India Respiratory Care Device Market By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables & Accessories), By Indication (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Diseases, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Company, By Region, Forecast & Opportunities, FY2027

Growing incidence of respiratory diseases is expected to drive the growth of India respiratory care device market during the forecast period.Read More

India Oxcarbazepine Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Seizures and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027

Growing cases of epilepsy in the country is expected to drive the growth of India oxcarbazepine market during the forecast period.Read More

India Levetiracetam Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Treatment (Myoclonic treatment, Tonic-clonic seizures treatment and Others), By Route of Administration (Oral v/s Intravenous), By Company, By Region, Forecast & Opportunities, FY2027

Growing epilepsy amongst population is expected to drive the growth of India levetiracetam market during the forecast period.Read More

India Piperacillin/Tazobactam Market By Route of Administration (Intravenous Injection v/s Intramuscular Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Intra-abdominal Infections, Nosocomial Pneumonia, Skin and Skin Structure Infections, Community acquired pneumonia and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2027

Growing cases of bacterial infections is expected to drive the growth of India piperacillin/tazobactam market during the forecast period.Read More

India Vildagliptin Market By Composition (Monotherapy vs. Combination), By Source (In-house vs. Contract Manufacturing Organizations), By Strength (50 mg, 100mg, Others), By Distribution Channel (Online vs. Offline), By Application (Type 2 Diabetes Mellitus vs. Hyperglycaemia), By Company, By Region, Forecast & Opportunities, FY2026

Increasing diabetic population to drive the growth of the India vildagliptin market.Read More

India Meropenem Market By Product Type (Meropenem Sodium v/s Meropenem Trihydrate), By Source (In-house v/s Contract Manufacturing Organizations), By Dose (500 mg/vial v/s 1gm/vial), By Distribution Channel (Online v/s Offline), By Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Increase in bacterial infections is expected to drive the growth of India meropenem market during the forecast period.Read More

India Active Pharmaceutical Ingredients Market By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Diseases, Skin Infections, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections, Others), By Form (Tablet, Capsule, Injection, Others), By Route of Administration (Oral v/s Intravenous), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Increasing incidence of chronic diseases is expected to drive the growth of India Active Pharmaceutical Ingredients market during the forecast period.Read More

Global Losartan Market By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026

Growing prevalence of hypertension is expected to drive the growth of the global losartan market.Read More

Global Osteoporosis Drugs Market By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, and Others), By Osteoporosis Disease Type (Primary Osteoporosis, Secondary Osteoporosis), By Route of Administration (Oral, Injectable, and Others), By Gender (Female, Male), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Forecast & Opportunities, 2026

Rising prevalence of osteoporosis and surge in the geriatric population is expected to drive the global osteoporosis drugs market through 2026.Read More

United States Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal, Others), By Form (Tablet, Capsule, Injection, Others), By Molecule Type (Small v/s Large), By Potency (High v/s Low), By Drug Type (Innovator v/s Generic), By Region, Competition Forecast & Opportunities, 2016 – 2026

The growing uptake of biopharmaceuticals is expected to drive the United States active pharmaceutical ingredient market through 2026 Read More

India Immunology Drugs Market By Drug Class (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication, Others), By Indication (Arthritis, Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant Rejection, Others), By Application (Hospitals, Clinics, Cancer Research Institute, Others), By Company, By Region, Forecast & Opportunities, FY2026

Increasing incidence of immunological diseases is expected to drive the growth of India immunology drugs market during the forecast period.Read More

   Page 1 of 5 Next

Designed & Developed By TechSci Research | Copyright @2019-20